Efficacy, Satisfaction, and Safety of the Mesolipo® Protocol for the Treatment of Localized Adipo… (NCT07743788) | Clinical Trial Compass
CompletedNot Applicable
Efficacy, Satisfaction, and Safety of the Mesolipo® Protocol for the Treatment of Localized Adiposity
Brazil12 participantsStarted 2025-01-01
Plain-language summary
This randomized, split-body clinical trial aims to evaluate the efficacy, safety, and participant satisfaction of the Mesolipo® protocol for the treatment of localized adiposity. Participants will receive the Mesolipo® intervention on one side of the body and an active comparator on the contralateral side. Outcomes will be assessed through standardized clinical, photographic, ultrasonographic, and patient-reported measures over a 90-day follow-up period to determine treatment effectiveness and safety.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults aged 18 years or older.
* Presence of localized adiposity suitable for treatment with the Mesolipo® protocol.
* Willingness and ability to provide written informed consent.
* Ability to comply with all study procedures and follow-up visits.
* Stable body weight for at least 3 months before enrollment.
* Agreement to maintain usual diet and physical activity habits throughout the study.
Exclusion Criteria:
* Pregnancy or breastfeeding.
* Known hypersensitivity to sodium deoxycholate or any study product component.
* Active infection or inflammatory skin disease at the treatment site.
* Previous aesthetic treatment in the target area within the period defined by the protocol.
* Severe systemic disease or any condition that, in the investigator's opinion, could interfere with study participation or outcome assessment.
* Participation in another clinical trial within the previous 30 days.
* Inability or unwillingness to comply with study procedures.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.